Biologics in Bronchiectasis: A Future Treatment?

Characterisation of Eosinophilic Bronchiectasis: A European Multicohort Study

(2022) Amelia Shoemark et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study

(2021) Holly R Keir et al.   Lancet Respiratory Medicine

T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis

(2021) Martina Oriano et al.   Biomedicines

Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations

(2021) Stefano Aliberti et al.   Lancet Respiratory Medicine

Role of inhaled corticosteroids in reducing exacerbations in bronchiectasis patients with blood eosinophilia pooled post-hoc analysis of 2 randomized clinical trials

(2020) Miguel Angel Martinez-Garcia et al.   RESPIRATORY MEDICINE

Anti-IL5 and anti-IL5Rα therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series

(2019) Jessica Rademacher et al.   EUROPEAN RESPIRATORY JOURNAL

The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions

(2018) Eva Polverino et al.   EUROPEAN RESPIRATORY JOURNAL

Treatable traits in bronchiectasis

(2018) Rita Boaventura et al.   EUROPEAN RESPIRATORY JOURNAL

Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity

(2018) Patrick A Flume et al.   LANCET

Bronchiectasis andAspergillus: How are they linked?

(2016) Anthony De Soyza et al.   MEDICAL MYCOLOGY